Published by La Vanguardia 2015-12-15. Oncomatryx expands capital to complete the preclinical phase of drugs against tumor stroma The Basque company Oncomatryx has completed a round of capital increase of 4.5 million euros with the aim of completing the preclinical trials of the “pioneer” molecule named OMTX, which has been developed against the tumor stroma, … Leer más

Press Release 2013-06-26 DMTXinvascan tested in US hospitals. Hospitals in the USA launch a Basque test to predict the metastasis of breast cancer Current diagnostic systems impede the detection in time of 25% of expanded tumors   A Spanish company develops a test that detects whether a breast cancer disease will develop metastasis Using this … Leer más

Publisehed by El Dato Magazine el 2013-01-01 New treatments against the most invasive cancer Develops in collaboration with renowned public and private national and foreign companies, new drugs that help to extend the patient’s life